Despite the lack of evidence linking RBMS1 SNPs and risk of PCa, it seems to be plausible to suggest that the presence of genetic variants in the RBMS1 locus might control miR-106b levels and, therefore, favors tumorigenesis. Here, RBMS1 is linked to posterior cortical atrophy.